1,492
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Regulation of birthweight by placenta-derived miRNAs: evidence from an arsenic-exposed birth cohort in Bangladesh

ORCID Icon, ORCID Icon, , , ORCID Icon, , , , , & ORCID Icon show all
Pages 573-590 | Received 12 Dec 2017, Accepted 07 May 2018, Published online: 13 Aug 2018

References

  • Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl. 2004;93:26–33.
  • Curhan GC, Willett WC, Rimm EB, et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94:3246–3250.
  • Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65:663–737.
  • Gude NM, Roberts CT, Kalionis B, et al. Growth and function of the normal human placenta. Thromb Res. 2004;114:397–407.
  • Morgan TK. Role of the Placenta in preterm birth: a review. Am J Perinatol. 2016;33:258–266.
  • Marsit CJ. Placental epigenetics in children’s environmental health. Semin Reprod Med. 2016;34:36–41.
  • Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21:243–251.
  • Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854.
  • Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866.
  • Hagen JW, Lai EC. microRNA control of cell-cell signaling during development and disease. Cell Cycle. 2008;7:2327–2332.
  • Pineles BL, Romero R, Montenegro D, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007;196:261 e1–6.
  • Bai Y, Yang W, Yang HX, et al. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One. 2012;7:e38875.
  • Enquobahrie DA, Abetew DF, Sorensen TK, et al. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011;204:178.e12–21.
  • Fu G, Brkic J, Hayder H, et al. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci. 2013;14:5519–5544.
  • Betoni JS, Derr K, Pahl MC, et al. MicroRNA analysis in placentas from patients with preeclampsia: comparison of new and published results. Hypertens Pregnancy. 2013;32:321–339.
  • Chen DB, Wang W. Human placental microRNAs and preeclampsia. Biol Reprod. 2013;88:130.
  • Hromadnikova I, Kotlabova K, Ivankova K, et al. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS One. 2017;12:e0171756.
  • Li Q, Long A, Jiang L, et al. Quantification of preeclampsia-related microRNAs in maternal serum. Biomed Rep. 2015;3:792–796.
  • Mayor-Lynn K, Toloubeydokhti T, Cruz AC, et al. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci. 2011;18:46–56.
  • Rodosthenous RS, Burris HH, Sanders AP, et al. Second trimester extracellular microRNAs in maternal blood and fetal growth: an exploratory study. Epigenetics. 2017.
  • Wang D, Na Q, Song WW, et al. Altered Expression of miR-518b and miR-519a in the placenta is associated with low fetal birth weight. Am J Perinatol. 2014;31:729–734.
  • Song GY, Song WW, Han Y, et al. Characterization of the role of microRNA-517a expression in low birth weight infants. J Dev Orig Health Dis. 2013;4:522–526.
  • Rager JE, Bailey KA, Smeester L, et al. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environ Mol Mutagen. 2014;55:196–208.
  • Rahman ML, Kile ML, Rodrigues EG, et al. Prenatal arsenic exposure, child marriage, and pregnancy weight gain: associations with preterm birth in Bangladesh. Environ Int. 2018;112:23–32.
  • Kile ML, Cardenas A, Rodrigues E, et al. Estimating effects of arsenic exposure during pregnancy on perinatal outcomes in a Bangladeshi cohort. Epidemiology. 2016;27:173–181.
  • Rahman ML, Valeri L, Kile ML, et al. Investigating causal relation between prenatal arsenic exposure and birthweight: are smaller infants more susceptible? Environ Int. 2017;108:32–40.
  • Hromadnikova I, Kotlabova K, Hympanova L, et al. Cardiovascular and cerebrovascular disease associated microRNAs are dysregulated in placental tissues affected with gestational hypertension, preeclampsia and intrauterine growth restriction. PLoS One. 2015;10:e0138383.
  • Hromadnikova I, Kotlabova K, Hympanova L, et al. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res. 2016;137:126–140.
  • Huang L, Shen Z, Xu Q, et al. Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta. 2013;34:624–627.
  • Choi SY, Yun J, Lee OJ, et al. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta. 2013;34:799–804.
  • Wu L, Zhou H, Lin H, et al. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction. 2012;143:389–397.
  • Li H, Ge Q, Guo L, et al. Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int. 2013;2013:970265.
  • Zhang C, Li Q, Ren N, et al. Placental miR-106a approximately 363 cluster is dysregulated in preeclamptic placenta. Placenta. 2015;36:250–252.
  • Ura B, Feriotto G, Monasta L, et al. Potential role of circulating microRNAs as early markers of preeclampsia. Taiwan J Obstet Gynecol. 2014;53:232–234.
  • Xu P, Zhao Y, Liu M, et al. Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension. 2014;63:1276–1284.
  • Hu Y, Li P, Hao S, et al. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med. 2009;47:923–929.
  • Schopman NC, Heynen S, Haasnoot J, et al. A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. RNA Biol. 2010;7:573–576.
  • de Grauw TJ, Myers RE, Scott WJ. Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate. 1986;49:85–89.
  • Liu S, Wen SW, Demissie K, et al. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2001;184:90–96.
  • Vaezi A, Haghighi L, Beigmohammadi F, et al. Maternal asthma, pregnancy, delivery and birth outcomes: a retrospective cohort study. Iran J Allergy Asthma Immunol. 2017;16:92–98.
  • Wu F, Tian FJ, Lin Y, et al. Oxidative stress: placenta function and dysfunction. Am J Reprod Immunol. 2016;76:258–271.
  • Whitehead CL, Teh WT, Walker SP, et al. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One. 2013;8:e78487.
  • Kulshreshtha R, Davuluri RV, Calin GA, et al. A microRNA component of the hypoxic response. Cell Death Differ. 2008;15:667–671.
  • Bai R, Zhao AQ, Zhao ZQ, et al. MicroRNA-195 induced apoptosis in hypoxic chondrocytes by targeting hypoxia-inducible factor 1 alpha. Eur Rev Med Pharmacol Sci. 2015;19:545–551.
  • Nakayama K. Cellular signal transduction of the hypoxia response. J Biochem. 2009;146:757–765.
  • Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999;84:695–701.
  • Ostlund E, Lindholm H, Hemsen A, et al. Fetal erythropoietin and endothelin-1: relation to hypoxia and intrauterine growth retardation. Acta Obstet Gynecol Scand. 2000;79:276–282.
  • Regnault TR, de Vrijer B, Galan HL, et al. The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction. J Physiol. 2003;550:641–656.
  • McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773:1263–1284.
  • Zhang GL, He ZM, Shi XM, et al. Discordant HIF1A mRNA levels and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction. Placenta. 2015;36:297–303.
  • Zamudio S, Wu Y, Ietta F, et al. Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. Am J Pathol. 2007;170:2171–2179.
  • Zhang WC, Chin TM, Yang H, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702.
  • Endo Y, Yamashita H, Takahashi S, et al. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. BMC Cancer. 2014;14:990.
  • Sim E, Abuhammad A, Ryan A. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Br J Pharmacol. 2014;171:2705–2725.
  • Ruttkay-Nedecky B, Nejdl L, Gumulec J, et al. The role of metallothionein in oxidative stress. Int J Mol Sci. 2013;14:6044–6066.
  • Rahman ML, Kile ML, Rodrigues EG, et al. Prenatal arsenic exposure, child marriage, and pregnancy weight gain: associations with preterm birth in Bangladesh. Environ Int. 2017;112:23–32.
  • Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 2007;3:1724–1735.
  • Adibi JJ, Hauser R, Williams PL, et al. Placental biomarkers of phthalate effects on mRNA transcription: application in epidemiologic research. Environ Health. 2009;8:20.
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399.
  • Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3. research0034.1–research0034.11.
  • Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18:137–150.
  • Hernan MA. A definition of causal effect for epidemiological research. J Epidemiol Community Health. 2004;58:265–271.
  • Tingley D, Yamamoto T, Hirose K, et al. mediation: R package for causal mediation analysis. J Stat Softw. 2013;59:1–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.